Abstract:Abstract Introduction We investigated the association between circadian rest/activity rhythms (RARs) and daytime insomnia symptoms among older adults with insomnia. We hypothesized that: 1) RARs differ between older adults with insomnia and healthy sleepers; and 2) among older adults with insomnia, RARs are associated with daytime insomnia symptoms. Methods Older adults with insomnia (n=30) and healthy sleepers (n=33) were recruited from a tertiary academic medical center. Nonparametric RARs were derived from actigraphy data over 14 days: relative amplitude (RA), interdaily stability (IS), intradaily variability (IV), maximum ten-hour activity (M10) and minimum five-hour activity (L5). Secondary parametric RARs included amplitude, acrophase, and midline statistics of rhythm (MESOR). Daytime function was evaluated via the Daytime Insomnia Symptoms Scale (administered via smartphone 4x/day, i.e., 56 assessments per participant) and validated research questionnaires (administered once). Between-groups differences (insomnia vs healthy sleep) were evaluated using t-tests. Among individuals with insomnia, a series of 104 linear regression models examined the association between RARs and daytime symptoms. The Benjamini-Hochberg procedure for correcting false discovery rate (BH-FDR) was used to correct for multiple comparisons. Results Relative to healthy sleepers, older adults with insomnia demonstrated significantly lower RA (p=0.028,t=-2.28) and significantly higher L5 (p=0.018,t=2.48). Among older adults with insomnia, IS was positively associated with positive mood (p=0.013, t =2.67) and negatively associated with pre-sleep somatic arousal (p=0.01, t=-3.06). IV was negatively associated with DISS subscales including Alert Cognition (p=0.001, t=-3.64) and Positive Mood (p< 0.001, t=-4.15) and positively associated with Negative Mood (p< 0.001, t=4.74), and Sleepiness/fatigue (p=0.005, t=3.11), as well as validated questionnaires measuring depression (p=0.02, t=2.47), negative mood (p< 0.01, t=3.43), and pre-sleep somatic arousal (p=0.01, t=3.77). M10 was negatively associated with depression (p< 0.0,1 t=-3.29) and anxiety (p=0.01 t=-2.9). Of parametric RARs, amplitude was negatively associated with negative mood (p=0.005, t=-3.08) and depression (p=0.01, t=-2.75), and positively associated with positive mood (p=0.010, t=2.77). MESOR was negatively associated with depression (p=0.02, t=-2.48) and anxiety (p=0.01, t=-2.81). Conclusion Among older adults with insomnia, RARs were associated with daytime insomnia symptoms. Future research should examine how to optimize circadian components of therapeutic interventions in insomnia clinical care. Support (if any) Merck Investigator Studies Program (#59170).

Nighttime Agitation in Persons with Dementia as a Manifestation of Restless Legs Syndrome

0687 RLS Treatment Reduces Nighttime Agitation and Increases Sleep Duration in Older Adults with Alzheimer's Disease

Symptoms of Restless Legs Syndrome in Older Adults: Outcomes on Sleep Quality, Sleepiness, Fatigue, Depression, and Quality of Life

Restless Legs Syndrome in a Group of Patients With Alzheimer’s Disease

Iron Deficiency and Restless Sleep/Wake Behaviors in Neurodevelopmental Disorders and Mental Health Conditions

Iron Deficiency and Sleep/Wake Behaviors: A Scoping Review of Clinical Practice Guidelines-How to Overcome the Current Conundrum?

The relationship between sleep disorders, anxiety, depression, and cognitive function with restless legs syndrome (RLS) in the elderly

Sleep, Cognition and Dementia

Treating Severe Refractory and Augmented Restless Legs Syndrome

Peripheral Iron Metabolism is Associated with Leg Movements on Polysomnography but Not with the Severity of Restless Legs Syndrome or Its Impact on Patients

0682 Circadian Rest/activity Rhythms Are Associated with Daytime Symptoms Among Older Adults with Insomnia

Restless legs syndrome in Parkinson disease: Clinical characteristics, abnormal iron metabolism and altered neurotransmitters

Restless Legs Syndrome across the Lifespan: Symptoms, Pathophysiology, Management and Daily Life Impact of the Different Patterns of Disease Presentation

Associations of 24‐Hour Rest‐Activity Rhythm Fragmentation, Cognitive Decline, and Postmortem Locus Coeruleus Hypopigmentation in Alzheimer's Disease

Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions

Dopamine agonists in restless leg syndrome treatment and their effects on sleep parameters: A systematic review and meta-analysis

Sleep disorders and their impacts on healthy, dependent, and frail older adults

Agitation in Dementia: Real-World Impact and Burden on Patients and the Healthcare System

Restless legs syndrome. Pathophysiology, diagnosis and treatment

Nocturnal disturbances and restlessness in Parkinson's disease: Using the Japanese version of the Parkinson's disease sleep scale-2